Contemporary use of cefazolin for MSSA infective endocarditis: Analysis of a national prospective cohort

Infective endocarditis (IE) is a life-threatening infectious disease characterized by its high morbimortality [1,2]. Today, Staphylococcus aureus is the most common cause of IE in developed countries[3,4] with a growing incidence in the last decades due to its relationship with health-care contact[1,3]. Particularly, S. aureus IE has been associated with immunosuppression, prosthetic cardiac devices, hemodialysis and other invasive procedures [3,4], as well as an aggressive presentation and poor prognosis[5].

Source: International Journal of Infectious Diseases - November 3, 2023 Category: Infectious Diseases Authors: L. Herrera-Hidalgo, P. Mu ñoz, A. Álvarez-Uría, D. Alonso-Menchén, R. Luque-Marquez, E. Gutiérrez-Carretero, MC. Fariñas, JM. Miró, MA Goenaga, LE. López-Cortés, B. Angulo-Lara, L. Boix-Palop, Arístides de Alarcón, Grupo de Apoyo al Manejo de l Source Type: research